If you're looking to put cash into two fantastic biotech stocks that Wall Street seems particularly bullish on, there's one ...

Tarrytown-based Regeneron Pharmaceuticals has reported financial results for its second quarter of 2025. Net revenues increased 4% from the $3.54 ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Second Quarter 2025 Results Key Financial Results Revenue: US$3.68b (up ...

The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

The pharmaceutical industry has long protested the idea of globally linked drug prices as a threat to years of U.S. dominance ...

AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...

Catch top deals, trends and themes across private markets in Asia this week.

Banque Cantonale Vaudoise has taken a significant position in Amgen Inc. (AMGN), scooping up 15,432 shares worth about $4.81 ...